Fernando Vidal-Vanaclocha obitained his MD at the University Valencia School Medicine and PhD at the Basque Country University in Bilbao, Spain.
He is full professor of Cell Biology and Human Histology, Vice Dean for Research and International Affairs and Scientific Director of the Institute of Applied Molecular Medicine (IMMA) at the CEU-San Pablo University School of Medicine (Madrid). Also, he is Chief Scientific Officer at Hospital of Madrid Scientific Foundation (Madrid) and Guest Scientist at the Women's Cancers Section, Lab. Molec. Pharmacol., NCI-NIH (Maryland).
Formerly, he served as Senior vicepresident for preclinical sciences at INBIOMED Foudation (Spain), as chief scientific officer at Pharmakine SL (Spain) and as scientific consultant at Biopharmance Inc (West Virginia, USA).
His basic research focuses in organ-specific models of cancer metastasis and angiogenesis, and on the effects of inflammation and oxidative stress in the regulation of metastatic cancer cell behavior. His translational research deals with molecular pathophysiology of cancer metastasis in patients with breast and gastrointestinal cancers, with special emphasis on the contribution of host genetics backgrounds to the functional microenvironment of metastasis-susceptible sites and the impact on the metastatic ability of cancer cells.
For information please contact email@example.com